A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back.

A new 'off-the-shelf' vaccine with the catchy name ELI-002 2P offers fresh hope for individuals affected by these deadly ...

It's still early but a one-size-fits-all vaccine is showing promise in helping stop aggressive pancreatic cancers from coming ...

An experimental vaccine targeting one of the most common genetic drivers of hard-to-treat pancreatic and colorectal cancers prevented their recurrence, raising hopes for an "off the shelf" treatment ...

The number of travel-related cases of chikungunya, a mosquito-borne viral infection, has nearly tripled in England during the ...

It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so.” Mark Twain’s quip ...

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...

The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...